Yahoo
Frankfurt - Delayed Quote EUR

Curaleaf Holdings, Inc. (2XW.F)

8.20 -0.18 (-2.15%)
As of 8:04:31 AM GMT+1. Market Open.
Chart Range Bar
Loading chart for 2XW.F
  • Previous Close 8.38
  • Open 8.19
  • Bid 8.16 x --
  • Ask 8.56 x --
  • Day's Range 8.19 - 8.19
  • 52 Week Range 5.22 - 10.28
  • Volume 182
  • Avg. Volume 127
  • Market Cap (intraday) 2.172B
  • Beta (5Y Monthly) 1.76
  • PE Ratio (TTM) --
  • EPS (TTM) -0.04
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.

www.curaleaf.com

5,554

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

2XW.F
25.05%
S&P/TSX Composite index (^GSPTSE)
13.46%

1-Year Return

2XW.F
25.05%
S&P/TSX Composite index (^GSPTSE)
20.87%

3-Year Return

2XW.F
25.05%
S&P/TSX Composite index (^GSPTSE)
85.13%

5-Year Return

2XW.F
25.05%
S&P/TSX Composite index (^GSPTSE)
67.73%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 352.65M
Earnings -32.72M
Profit Margin -9.28%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
300M
-10.0%
0.0%
10.0%
20.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.76%

  • Return on Assets (ttm)

    0.24%

  • Return on Equity (ttm)

    -0.50%

  • Revenue (ttm)

    1.35B

  • Net Income Avi to Common (ttm)

    -16.89M

  • Diluted EPS (ttm)

    -0.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    92.39M

  • Total Debt/Equity (mrq)

    133.56%

  • Levered Free Cash Flow (ttm)

    70.95M

Company Insights

Research Reports

View More
Mobilize your Website
View Site in Mobile | Classic
Share by: